Correlation Between Zoetis and Sunshine Biopharma

Can any of the company-specific risk be diversified away by investing in both Zoetis and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zoetis and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zoetis Inc and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Zoetis and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zoetis with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zoetis and Sunshine Biopharma.

Diversification Opportunities for Zoetis and Sunshine Biopharma

0.14

Correlation Coefficient

Zoetis  Sunshine Biopharma

Average diversification

The 3 months correlation between Zoetis and Sunshine is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Zoetis Inc and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Zoetis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zoetis Inc are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Zoetis i.e., Zoetis and Sunshine Biopharma go up and down completely randomly.

Pair Corralation between Zoetis and Sunshine Biopharma

Considering the 90-day investment horizon Zoetis is expected to generate 168.94 times less return on investment than Sunshine Biopharma. But when comparing it to its historical volatility, Zoetis Inc is 24.19 times less risky than Sunshine Biopharma. It trades about 0.02 of its potential returns per unit of risk. Sunshine Biopharma Warrant is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  16.00  in Sunshine Biopharma Warrant on December 30, 2024 and sell it today you would earn a total of  4.00  from holding Sunshine Biopharma Warrant or generate 25.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	93.55%
Values	Daily Returns

Zoetis Inc  vs.  Sunshine Biopharma Warrant

Zoetis Inc

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Zoetis Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Zoetis is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Sunshine Biopharma

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sunshine Biopharma Warrant are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating primary indicators, Sunshine Biopharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Zoetis and Sunshine Biopharma

The main advantage of trading using opposite Zoetis and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zoetis position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.

The idea behind Zoetis Inc and Sunshine Biopharma Warrant pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..